20+ years in India
IAVI India and the Government of India partner for globally accessible vaccines and antibodies. Our India hub has an office with 25+ staff members in Gurugram and our laboratory, the Antibody Translational Research Program (ATRP), in Faridabad, Haryana at the NCR Biotech Science Cluster.
India’s rising significance and commitment to health research and development (R&D) has been pivotal in redefining the boundaries of biomedical innovation, in-country and globally. India is the largest vaccine supplier in the world, with globally competitive R&D capabilities supporting low-cost product development. India’s prominence in this area has enabled IAVI to create and strengthen a regional network of research centers of excellence that complement IAVI’s global scientific network.
- Community engagement or community partnership, as we are now calling it, is at the core of product development at every stage in the entire process. We need communities to play a central role. So, we should realize that community engagement is also a science.Joyeeta Mukherjee Associate Director, Access, Research, & Development
- The young, talented female researchers who love science and are passionate about science should not leave behind their dreams. If you dream something, if you wish to do something, you should never stop until you reach your goal. Sohini Mukherjee Senior Specialist, Antibody Translational Research Program